Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Health Insurance > Health Insurance

HIV survivors seek drug advances as FDA eases approvals

X
Your article was successfully shared with the contacts you provided.

The Federal Drug Administration (FDA) is close to relaxing some of its rules regarding the development of new HIV drugs. In order to avail long-term HIV patients of the constantly changing drugs they need to avoid mutation of the virus, the FDA is looking to curtail some of their more onerous research and regulatory requirements.